Ads
related to: coronavirus treatment news
Search results
Momentum for drug discount program reform
Politico· 4 days agoRon Wyden (D-Ore.). Recommendations: The GAO called on CMS to offer written expectations for state monitoring and to “clearly define” when plans can mandate prior authorization for screening ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoToday, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals ...
After Grilling an NIH Scientist Over Covid Emails, Congress Turns to Anthony Fauci
North Denver News· 3 days agoFormer National Institutes of Health official Anthony Fauci has faced many hostile questions from members of Congress, but when he appears before a House panel on Monday, he’ll have something ...
After grilling an NIH scientist over COVID emails, Congress turns to Anthony Fauci
St. Louis Post-Dispatch· 3 days agoFormer National Institutes of Health official Anthony Fauci has faced many hostile questions from...
Pentagon mulls special pay boost to fix health care personnel shortage
Federal Times· 5 days agoPentagon officials said they will look to increase pay for health care workers, especially nurses,...
Stanford study suggests new ways of predicting, treating breast cancer through genes
Newsday· 4 days agoA new study has found that the genes people are born with — and how they interact with the immune...
Trump conviction puts the US in unchartered legal, electoral territory
CBS Austin· 3 days agoThe conviction of former President Donald Trump on 34 felonies in his New York hush money case...
After Grilling an NIH Scientist Over COVID Emails, Congress Turns to Fauci
MedPage Today· 3 days agoFormer NIH official Anthony Fauci, MD, has faced many hostile questions from members of Congress,...
Swiss National Bank Boosts Stock Position in Verve Therapeutics, Inc. (NASDAQ:VERV)
ETF DAILY NEWS· 7 days agoSwiss National Bank lifted its position in Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) by 13.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 108,500 shares of ...
